PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology

被引：9
作者：
von Knethen, Andreas [1 ]
Bruene, Bernhard [1 ]
机构：
[1] Goethe Univ Frankfurt, Fac Med, Inst Biochem Pathobiochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2019年 / 4卷 / 1期
关键词：
D O I：
10.1038/s41392-019-0053-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 5 条
  • [1] The intracellular signalosome of PD-L1 in cancer cells
    Escors, David
    Gato-Canas, Maria
    Zuazo, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Vera, Ruth
    Kochan, Grazyna
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
  • [2] Atypical autoimmune adverse effects with checkpoint blockade therapies
    Friedman, C. F.
    Snyder, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (02) : 206 - 207
  • [3] Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling
    Runkle, Kristin B.
    Kharbanda, Akriti
    Stypulkowski, Ewa
    Cao, Xing-Jun
    Wang, Wei
    Garcia, Benjamin A.
    Witze, Eric S.
    [J]. MOLECULAR CELL, 2016, 62 (03) : 385 - 396
  • [4] Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
    Wang, Yiting
    Wang, Huanbin
    Yao, Han
    Li, Chushu
    Fang, Jing-Yuan
    Xu, Jie
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [5] Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
    Yao, Han
    Lan, Jiang
    Li, Chushu
    Shi, Hubing
    Brosseau, Jean-Philippe
    Wang, Huanbin
    Lu, Haojie
    Fang, Caiyun
    Zhang, Yao
    Liang, Lunxi
    Zhou, Xiaolin
    Wang, Chaojun
    Xue, Yu
    Cui, Yun
    Xu, Jie
    [J]. NATURE BIOMEDICAL ENGINEERING, 2019, 3 (04) : 306 - 317
1